Paper25366362
Experience with molecular adsorbent recirculating system treatment in 20 children listed for high-urgency liver transplantation.
Lexmond WS and 7 others. Liver Transpl, 2015. Cited by 31 papers, by iCite.
Cite this record
ConductScience Library. Experience with molecular adsorbent recirculating system treatment in 20 children listed for high-urgency liver transplantation. Papers, record 25366362. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25366362
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Experience with molecular adsorbent recirculating system treatment in 20 children listed for high-urgency liver transplantation.
- PubMed
Topics22
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| End Stage Liver Disease | Major topic |
| Hepatic Encephalopathy | Major topic |
| Liver Transplantation | Major topic |
| Sorption Detoxification | Major topic |
| Waiting Lists | Major topic |
| Adolescent | |
| Age Factors | |
| Case-Control Studies | |
| Child | |
| Child, Preschool | |
| Disease Progression | |
| Female | |
| Humans | |
| Infant | |
| Infant, Newborn | |
| Male | |
| Protein Binding | |
| Serum Albumin | |
| Serum Albumin, Human | |
| Severity of Illness Index | |
| Time Factors | |
| Treatment Outcome |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 25376162 | Is the molecular adsorbent recirculating system the answer for children with acute liver failure? | https://conductscience.org/library/papers/25376162 |
Source PubMed
Cited by14
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 31 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39937316 | Molecular adsorbent recirculating system (MARS®) and continuous renal replacement therapy for the treatment of paediatric acute liver failure - two-centre retrospective cohort study. | Eur J Pediatr | 2025 | https://conductscience.org/library/papers/39937316 | PubMed |
| 38466551 | Pediatric acute liver failure: Current perspective in etiology and management. | Indian J Gastroenterol | 2024 | https://conductscience.org/library/papers/38466551 | PubMed |
| 37954902 | Molecular Adsorbent Recirculating System for Acute Liver Failure in a New Pediatric-Based Extracorporeal Liver Support Program. | Crit Care Explor | 2023 | https://conductscience.org/library/papers/37954902 | PubMed |
| 37587287 | Live donor liver transplantation for pediatric acute liver failure: challenges and outcomes. | Hepatol Int | 2023 | https://conductscience.org/library/papers/37587287 | PubMed |
| 36006605 | Therapeutic Management of Idiosyncratic Drug-Induced Liver Injury and Acetaminophen Hepatotoxicity in the Paediatric Population: A Systematic Review. | Drug Saf | 2022 | https://conductscience.org/library/papers/36006605 | PubMed |
| 35773246 | Indeterminate pediatric acute liver failure: Clinical characteristics of a temporal cluster of five children in the Netherlands in the spring of 2022. | United European Gastroenterol J | 2022 | https://conductscience.org/library/papers/35773246 | PubMed |
| 32500250 | Extracorporeal renal and liver support in pediatric acute liver failure. | Pediatr Nephrol | 2021 | https://conductscience.org/library/papers/32500250 | PubMed |
| 30443736 | Artificial liver support systems: what is new over the last decade? | Ann Intensive Care | 2018 | https://conductscience.org/library/papers/30443736 | PubMed |
| 30317782 | [Advances in the application of regional citrate anticoagulation for continuous renal replacement therapy in patients with liver failure]. | Zhonghua Gan Zang Bing Za Zhi | 2018 | https://conductscience.org/library/papers/30317782 | PubMed |
| 29108186 | [Changes and perspectives of non-biological artificial liver treatment]. | Zhonghua Gan Zang Bing Za Zhi | 2017 | https://conductscience.org/library/papers/29108186 | PubMed |
| 28792509 | Regional citrate anticoagulation for continuous renal replacement therapy in pediatric patients with liver failure. | PLoS One | 2017 | https://conductscience.org/library/papers/28792509 | PubMed |
| 28443154 | Drug-induced liver injury: Do we know everything? | World J Hepatol | 2017 | https://conductscience.org/library/papers/28443154 | PubMed |
| 28127473 | Hemadsorption with Adult CytoSorb® in a Low Weight Pediatric Case. | Case Rep Crit Care | 2017 | https://conductscience.org/library/papers/28127473 | PubMed |
| 28079174 | Alleviating liver failure conditions using an integrated hybrid cryogel based cellular bioreactor as a bioartificial liver support. | Sci Rep | 2017 | https://conductscience.org/library/papers/28079174 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| ALB | 213 | PubTator's text mining | https://conductscience.org/library/genes/213 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/25366362
GET https://conductscience.org/api/papers/v1/25366362/authors